Panagora Asset Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-578
| Closed | -$22K | – | 2848 |
|
|
2021
Q1 | $22K | Buy |
578
+438
| +313% | +$16.7K | ﹤0.01% | 2299 |
|
|
2020
Q4 | $7K | Sell |
140
-1,601
| -92% | -$80.1K | ﹤0.01% | 2375 |
|
|
2020
Q3 | $56K | Buy |
1,741
+43
| +3% | +$1.38K | ﹤0.01% | 1988 |
|
|
2020
Q2 | $75K | Buy |
+1,698
| New | +$75K | ﹤0.01% | 1886 |
|
|
2019
Q2 | – | Sell |
-8
| Closed | – | – | 2640 |
|
|
2019
Q1 | $0 | Sell |
8
-3
| -27% | – | ﹤0.01% | 2530 |
|
|
2018
Q4 | $1K | Buy |
11
+3
| +38% | +$273 | ﹤0.01% | 2422 |
|
|
2018
Q3 | $1K | Sell |
8
-2,485
| -100% | -$311K | ﹤0.01% | 2386 |
|
|
2018
Q2 | $218K | Buy |
2,493
+2,485
| +31,063% | +$217K | ﹤0.01% | 1629 |
|
|
2018
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 2309 |
|
|
2017
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 2282 |
|
|
2017
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 2394 |
|
|
2017
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 2626 |
|
|
2017
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 2348 |
|
|
2016
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 2346 |
|
|
2016
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 2401 |
|
|
2016
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 2291 |
|
|
2016
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 2266 |
|
|
2015
Q4 | $3K | Hold |
8
| – | – | ﹤0.01% | 2267 |
|
|
2015
Q3 | $4K | Sell |
8
-18
| -69% | -$9K | ﹤0.01% | 2269 |
|
|
2015
Q2 | $56K | Hold |
26
| – | – | ﹤0.01% | 2115 |
|
|
2015
Q1 | $60K | Sell |
26
-8
| -24% | -$18.5K | ﹤0.01% | 2054 |
|
|
2014
Q4 | $70K | Hold |
34
| – | – | ﹤0.01% | 1947 |
|
|
2014
Q3 | $67K | Sell |
34
-16
| -32% | -$31.5K | ﹤0.01% | 1954 |
|
|
2014
Q2 | $177K | Hold |
50
| – | – | ﹤0.01% | 1753 |
|
|
2014
Q1 | $186K | Sell |
50
-2
| -4% | -$7.44K | ﹤0.01% | 1769 |
|
|
2013
Q4 | $169K | Hold |
52
| – | – | ﹤0.01% | 1721 |
|
|
2013
Q3 | $216K | Buy |
52
+14
| +37% | +$58.2K | ﹤0.01% | 1643 |
|
|
2013
Q2 | $129K | Buy |
+38
| New | +$129K | ﹤0.01% | 1793 |
|